This inventor holds 45 USPTO granted patents and 5 published patent applications and 10 EPO patents, primarily in TGF-beta Inhibitors. Top assignees: Rigel Pharmaceuticals, Incorporated, Bristol-Myers Squibb Compnay, Bristol Meyers Squibb Company. Active years: 2005-2025.
Location History:
- Mountain View, CA (US) (2006)
- Fayetteville, NC (US) (2005 - 2009)
- South San Francisco, CA (US) (2020)
- Redwood City, CA (US) (2007 - 2022)
Company Filing History:
44 out of 492 
3 out of 3,736 
1 out of 41 Years Active: 2005-2025
Areas of Expertise:
Title: Innovations and Contributions of Todd M Kinsella in Pharmaceutical Patents
Introduction: Todd M Kinsella, a prominent inventor based in Fayetteville, NC, has made significant strides in the field of pharmaceuticals, holding an impressive portfolio of 45 patents. His work primarily focuses on the development of innovative compounds and methods that target critical biological pathways, contributing to advancements in medical treatments.
Latest Patents: Among Todd M Kinsella's notable innovations are his latest patents concerning TGF-β inhibitors. These patents disclose pyrazole compounds as well as pharmaceutical compositions and methods of use. One embodiment of these compounds includes a structure alongside pharmaceutically acceptable salts, prodrugs, and N-oxides, with useful solvates and hydrates. The compounds are designed to inhibit the activity of various members of the TGF-β superfamily, which can be utilized in treating diseases by effectively blocking their activity.
Career Highlights: Throughout his career, Todd has held significant positions at various reputable companies, including Rigel Pharmaceuticals, Incorporated and Bristol-Myers Squibb Company. His extensive experience in these organizations has equipped him with the knowledge and skills to advance his innovative research.
Collaborations: Kinsella has collaborated with key professionals in the industry, including coworkers Mark K Bennett and Marina Gelman. These partnerships have facilitated the exchange of ideas and expertise, propelling the development of groundbreaking pharmaceutical solutions.
Conclusion: Todd M Kinsella stands out as a remarkable inventor in the pharmaceutical domain, with a rich portfolio of patents that reflect his dedication to innovation. His contributions to the field of TGF-β inhibitors exemplify the potential impact of inventive research in addressing complex health issues.